COVID-19 Vaccine Second Booster Authorization A ‘Stopgap Measure,’ US FDA’s Marks Says

 
• By Sue Sutter
COVID vaccine booster
A "stopgap measure" is how FDA's Peter Marks described the recent authorization of a second COVID-19 vaccine booster dose. • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers